Monopril (Fosinopril Sodium)

Fosinopril, the active ingredient in Monopril, is an angiotensin-converting enzyme (ACE) inhibitor presented as an oral tablet for oral use. It is employed to manage high blood pressure and to support treatment of heart failure in adult patients, helping to reduce cardiovascular risk and improve long‑term outcomes.

GNH USA supplies Monopril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams across global markets, ensuring reliable access to quality‑assured medication for healthcare providers worldwide.

Monopril (fosinopril) acts on the renin‑angiotensin system to lower blood pressure and improve cardiac function.

Hypertension: reduces systolic and diastolic pressure, decreasing cardiovascular strain. Heart failure: improves ventricular performance and lessens symptoms such as dyspnea and edema. Post‑myocardial infarction: helps lower mortality risk by attenuating adverse cardiac remodeling.

Fosinopril may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Cough: dry, persistent cough often reported early in therapy. - Dizziness: light‑headedness, especially after the first dose or dose increase. - Headache: mild to moderate intensity. - Fatigue: general tiredness without exertion. - Hypotension: symptomatic low blood pressure, particularly in volume‑depleted patients. - Taste disturbance: altered or metallic taste.

Serious or Rare Side Effects: - Angioedema: swelling of lips, tongue or airway requiring immediate medical attention. - Severe hypotension: marked drop in blood pressure leading to fainting or shock. - Renal impairment: worsening kidney function, indicated by rising creatinine. - Hepatic enzyme elevation: significant increase in liver transaminases. - Neutropenia: marked reduction in white blood cells increasing infection risk. - Anaphylactoid reaction: severe allergic response with rash and respiratory distress.

When prescribing or dispensing Monopril, several precautionary measures should be observed.

- Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess renal function: evaluate serum creatinine and eGFR before and during therapy. - Check electrolytes: especially potassium levels to prevent hyperkalaemia. - Use caution in pregnancy: limited data; avoid unless benefits outweigh risks. - Avoid in patients with prior angioedema: history of swelling related to ACE inhibitors contraindicates use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Fosinopril can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Aliskiren: combined use may increase risk of renal dysfunction and hyperkalaemia. - Lithium: fosinopril can raise lithium concentrations, leading to toxicity. - Potassium‑sparing diuretics: concurrent use may cause dangerous hyperkalaemia.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect and affect kidney function. - Diuretics: may enhance hypotensive response; monitor blood pressure and electrolytes.